REGENXBIO Inc.RGNXNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-6.65
↓ 50% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-4.45
Historical baseline
PeriodValueYoY Change
2025-6.65-223.9%
2024-2.05+41.4%
2023-3.51+12.3%
2022-4.00-160.0%
20216.66+145.2%
2020-14.72+8.0%
2019-16.00-200.5%
201815.92+223.1%
2017-12.93-80.1%
2016-7.18-